Information  X 
Enter a valid email address

Karolinska Development AB (pub (0P3C)

  Print   

Thursday 21 December, 2017

Karolinska Development AB (pub

BioArctic, a company in Karolinska Development's portfolio, announces that the Phase 2b study of BAN2401 in early Alzheimer's Disease continues toward 18-month endpoint 

YASTEST

a d v e r t i s e m e n t